Viewing Study NCT04705350


Ignite Creation Date: 2025-12-24 @ 5:25 PM
Ignite Modification Date: 2026-01-02 @ 5:05 AM
Study NCT ID: NCT04705350
Status: COMPLETED
Last Update Posted: 2022-07-19
First Post: 2021-01-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Test Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Ascending Intravenous Doses of Zampilimab in Healthy Participants
Sponsor: UCB Biopharma SRL
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2021-01-11
Start Date Type: ACTUAL
Primary Completion Date: 2021-07-28
Primary Completion Date Type: ACTUAL
Completion Date: 2021-07-28
Completion Date Type: ACTUAL
First Submit Date: 2021-01-08
First Submit QC Date: None
Study First Post Date: 2021-01-12
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2022-07-15
Last Update Post Date: 2022-07-19
Last Update Post Date Type: ACTUAL